Orion Infusion Limited reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was BDT 181.41 million compared to BDT 168.01 million a year ago. Net income was BDT 9.15 million compared to BDT 6.71 million a year ago. Basic earnings per share from continuing operations was BDT 0.45 compared to BDT 0.33 a year ago.
For the nine months, sales was BDT 612.15 million compared to BDT 493.8 million a year ago. Net income was BDT 29.14 million compared to BDT 22.77 million a year ago. Basic earnings per share from continuing operations was BDT 1.43 compared to BDT 1.12 a year ago.